Radiation-Free lung MRI could change how we diagnose scarring lung disease
NCT ID NCT03078426
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a special lung MRI can replace CT scans for diagnosing idiopathic pulmonary fibrosis (IPF), a scarring lung disease. Researchers compared MRI to standard CT in 60 patients to see if MRI could spot the same key signs of IPF without using radiation. The goal is to offer a safer, non-invasive imaging option for people with this condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MRI scan
- What this could lead to
- If successful, MRI could become a radiation-free alternative to CT scans for diagnosing and monitoring idiopathic pulmonary fibrosis.
- What could go wrong
- This is a small, completed study (60 participants) comparing MRI to the standard CT. MRI may not be as accurate, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HYPERSENSITIVITY PNEUMONITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Bordeaux
Pessac, 33604, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
- AI outruns radiologists in detecting early lung scarring
- Experimental drug aims to slow lung scarring in IPF
- AI-Designed drug targets scarred lungs in major trial
- Can scans replace breathing tests to monitor lung scarring?